These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8217800)

  • 21. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin cofactor II levels are increased by the use of combined oral contraceptives.
    Mackie IJ; Segal H; Burren T; Gallimore M; Walshe KJ; Robinson G; Machin SJ
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):647-51. PubMed ID: 2133244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hormone replacement therapy on anti-thrombin III activity in post menopausal women.
    Varma TR; Patel RH; Rosenberg D
    Int J Gynaecol Obstet; 1986 Feb; 24(1):69-73. PubMed ID: 2874074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breed, age, and gender differences in plasma antithrombin-III activity in clinically normal young horses.
    Johnstone IB; Physick-Sheard P; Crane S
    Am J Vet Res; 1989 Oct; 50(10):1751-3. PubMed ID: 2802307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.
    Robinson GE; Burren T; Mackie IJ; Bounds W; Walshe K; Faint R; Guillebaud J; Machin SJ
    BMJ; 1991 Feb; 302(6771):269-71. PubMed ID: 1998792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary report on the relationship between serum anti-thrombin III concentration in pre- and post-operative patients and in women on oral contraceptives.
    Ton SH; Lopez CG; Thiruselvam A; Lyou YT
    Med J Malaysia; 1981 Dec; 36(4):212-4. PubMed ID: 7334955
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombin inhibitors in women on oral contraceptives.
    Guagnellini E; Bertolini G; Cappelletti M; Colombo G
    Acta Haematol; 1981; 65(3):205-10. PubMed ID: 6165217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal status.
    Franchi F; Biguzzi E; Martinelli I; Bucciarelli P; Palmucci C; D'Agostino S; Peyvandi F
    Thromb Res; 2013 Aug; 132(2):e152-7. PubMed ID: 23920430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of antithrombin III.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):276-87. PubMed ID: 6758119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man.
    Boneu B; Necciari J; Cariou R; Sié P; Gabaig AM; Kieffer G; Dickinson J; Lamond G; Moelker H; Mant T
    Thromb Haemost; 1995 Dec; 74(6):1468-73. PubMed ID: 8772222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The VITA Project: population-based distributions of protein C, antithrombin III, heparin-cofactor II and plasminogen--relationship with physiological variables and establishment of reference ranges.
    Rodeghiero F; Tosetto A
    Thromb Haemost; 1996 Aug; 76(2):226-33. PubMed ID: 8865536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity of endogenous anticoagulants (antithrombin III, protein C and protein S) in women after menopause treated with hormone replacement therapy (transdermal 17 beta-OH estradiol and oral medroxyprogesterone acetate)].
    Ciepłuch R; Czestochowska E
    Ginekol Pol; 1996 Aug; 67(8):407-10. PubMed ID: 9139010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Menopausal status associated with increased inhibition of blood coagulation.
    Notelovitz M; Kitchens CS; Rappaport V; Coone L; Dougherty M
    Am J Obstet Gynecol; 1981 Sep; 141(2):149-52. PubMed ID: 6974498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
    Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
    Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dosage of antithrombin III in women taking oral contraceptives].
    Agoumi N; Messerschmitt C; Nejjar C; Guon VL
    Maghrib Tibbi; 1980 Oct; 2(3):309-15. PubMed ID: 7230892
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in antithrombin III levels in pregnancy, labour and in women on the contraceptive pill.
    Essien EM
    Afr J Med Med Sci; 1977 Sep; 6(3):109-13. PubMed ID: 97938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [State of health of populations residing in geothermal areas of Tuscany].
    Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
    Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.